Investigational protease inhibitors as antiretroviral therapies. - Wikidata - awgldk - TriplyDB

Investigational protease inhibitors as antiretroviral therapies.

Investigational protease inhibitors as antiretroviral therapies.

http://www.wikidata.org/entity/Q37582521

about

Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.

P2860

Q45324711-AFE5B62E-5973-44B0-A6AC-17CFC162274A

P2860

Investigational protease inhibitors as antiretroviral therapies.

http://www.wikidata.org/entity/Q37582521

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Investigational protease inhibitors as antiretroviral therapies.

@en

Investigational protease inhibitors as antiretroviral therapies.

@nl

type

label

Investigational protease inhibitors as antiretroviral therapies.

@en

Investigational protease inhibitors as antiretroviral therapies.

@nl

prefLabel

Investigational protease inhibitors as antiretroviral therapies.

@en

Investigational protease inhibitors as antiretroviral therapies.

@nl

P1433

Q37582521-FC04BEE7-8A05-4529-9428-8E902066832E

P1476

Q37582521-88359673-F492-4312-8423-803377E10A0C

P2093

Q37582521-4DCDA8D6-AAA7-46C8-8866-0602B3B68CFB

Q37582521-78719B46-5A4E-4CA3-98D9-7034A5983087

Q37582521-987725B8-95CA-4F6B-A3A8-CBC7FC395FC7

Q37582521-BD563710-5D3D-4C79-A98E-A5DD44257C52

Q37582521-D83F60E2-DBFD-4BD4-9A37-240E718F18F2

P2860

Q37582521-07FC8557-3AD5-42F9-ACC5-D2AD739F60A7

Q37582521-08EFFF23-78EC-45D8-B8F1-0686E7536287

Q37582521-0AD849FC-228F-4D3F-8FA9-A49C85D49E7B

Q37582521-0B7B9790-BBDF-4645-9E41-C4961949528F

Q37582521-1083C23C-F7FB-427B-A614-A0A25249F6BE

Q37582521-16CE3B95-35BF-4EC6-8EBC-23187388DD29

Q37582521-1ACE5B92-50EE-4069-ACF6-704D4FE3BC76

Q37582521-20C376FB-6CD5-4FE5-BC62-7A0698F0CDBE

Q37582521-2102F5D0-6D4C-4DE3-9A36-502B9015B90C

Q37582521-22A4FFD6-BE88-45F9-96B4-89A9A245FF2D

P304

Q37582521-9B08E0ED-BB0B-472F-B5A0-DBA91096F98F

P31

Q37582521-AEFC5D6D-D9B6-4199-9086-69E81EB3D887

P356

Q37582521-E3E2A021-2752-4B3F-B734-6B51BB1D90BE

P407

Q37582521-7883146D-EA18-49C6-80D2-971691E43841

P433

Q37582521-EF6D9066-D61B-4CEB-83D6-E2249263595A

P478

Q37582521-8533A3EA-455B-4F1E-A184-4D10C03149CD

P577

Q37582521-C68FAD17-C6AC-4247-A9EB-8F962FF5B298

P698

Q37582521-8A288580-6175-41DB-8B5E-A94C07F08C02

P921

Q37582521-3DCA715A-8085-4C5A-94CA-947CA3524203

P932

Q37582521-998717AC-3874-4A16-86A4-E828856C589C

P356

13543784.2016.1212837

P1433

Expert Opinion on Investigational Drugs

P1476

Investigational protease inhibitors as antiretroviral therapies.

@en

P2093

Benjamin J Patters

http://www.w3.org/2001/XMLSchema#string

Narasimha M Midde

http://www.w3.org/2001/XMLSchema#string

Pss Rao

http://www.w3.org/2001/XMLSchema#string

Santosh Kumar

http://www.w3.org/2001/XMLSchema#string

Theodore J Cory

http://www.w3.org/2001/XMLSchema#string

P2860

Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV

Rationale and clinical utility of the darunavir-cobicistat combination in the treatment of HIV/AIDS

Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence

Anti-HIV-1 nanotherapeutics: promises and challenges for the future

HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant Variants

Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors

TMC310911, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, Shows In Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared with Current Protease Inhibitors

Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors

Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

P304

1189-1200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2016.1212837

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27415449

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5228633

http://www.w3.org/2001/XMLSchema#string